A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma

NCT00000996 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

NIH

Sponsor class

Conditions

Sarcoma, Kaposi
HIV Infections

Interventions

DRUG: Doxorubicin hydrochloride

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)